UK Markets close in 5 hrs 32 mins

Omeros Corporation (OMER)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.97-0.03 (-0.20%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5933.01M
Enterprise value 31.23B
Trailing P/E N/A
Forward P/E 1-10.18
PEG ratio (5-yr expected) 1-0.11
Price/sales (ttm)12.64
Price/book (mrq)N/A
Enterprise value/revenue 316.63
Enterprise value/EBITDA 7-11.26

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 325.46
52-week low 39.25
50-day moving average 316.49
200-day moving average 317.66

Share statistics

Avg vol (3-month) 3587.52k
Avg vol (10-day) 3480.57k
Shares outstanding 562.33M
Implied shares outstanding 6N/A
Float 55.07M
% held by insiders 14.39%
% held by institutions 155.69%
Shares short (14 Apr 2021) 413.93M
Short ratio (14 Apr 2021) 424.73
Short % of float (14 Apr 2021) 423.53%
Short % of shares outstanding (14 Apr 2021) 422.50%
Shares short (prior month 14 Mar 2021) 413.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 301 Oct 2009

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin -187.04%
Operating margin (ttm)-149.84%

Management effectiveness

Return on assets (ttm)-43.47%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)73.81M
Revenue per share (ttm)1.29
Quarterly revenue growth (yoy)-68.20%
Gross profit (ttm)-31.57M
EBITDA -108.98M
Net income avi to common (ttm)-138.06M
Diluted EPS (ttm)-2.41
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)134.95M
Total cash per share (mrq)2.18
Total debt (mrq)268.84M
Total debt/equity (mrq)N/A
Current ratio (mrq)4.12
Book value per share (mrq)-1.96

Cash flow statement

Operating cash flow (ttm)-100.09M
Levered free cash flow (ttm)-61.96M